ACCELERATE DIAGNOSTICS INC AXDX 2.5 03.15.23
NOTE 2.500% 3/1 · US DOMESTIC · CUSIP 00430HAB8
9
institutional holders
+0 vs Q3 2022
3.0m
shares reported held*
$36.2mreported value*
0 new
1 added
1 reduced
0 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $12.08.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 9 |
| Q4 2022 | 9 |
Biggest buyers
| ROYAL BANK OF CANADA | Added | +5.0m |
Biggest sellers
| Indaba Capital Management, L.P. | Reduced | -5.0m |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Indaba Capital Management, L.P. 3.08% of their portfolio | 17.2m $15.9m | Reduced -5.0m |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 10.5m $9.2m | Added +5.0m |
| WOLVERINE ASSET MANAGEMENT LLC 0.06% of their portfolio | 4.0m $3.8m | Unchanged |
| Bruce & Co., Inc. 0.71% of their portfolio | 3.0m $2.8m | Unchanged |
| JANE STREET GROUP, LLC 0.01% of their portfolio | 3.0m $2.8m | Unchanged |
| PenderFund Capital Management Ltd. 0.72% of their portfolio | 1.9m $2.4k | Unchanged |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 1.0m $1.0m | Unchanged |
| INGALLS & SNYDER LLC 0.04% of their portfolio | 769.0k $710.0k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |